阿奇霉素联合痰热清治疗小儿肺炎支原体肺炎疗效

Efficacy on Mycoplasma Pneumonia Treated with Azithromycin and Tanreqing Injection in Children

目的观察阿奇霉素联合痰热清治疗小儿肺炎支原体肺炎的临床疗效。方法将90例确诊为肺炎支原体肺炎的患儿随机分为治疗组45例和对照组45例。对照组单用阿奇霉素序贯治疗,治疗组在阿奇霉素序贯治疗的基础上联合痰热清治疗。观察两组的退热时间、咳嗽消失时间、肺部啰音消失时间及胸片吸收好转时间等临床疗效。结果治疗组总有效率97.8%,对照组总有效率80.0%,两组差异有统计学意义(P<0.05)。治疗组的退热时间、咳嗽消失时间、肺部啰音消失时间及胸片吸收好转时间均明显短于对照组(P<0.05)。结论阿奇霉素联合痰热清治疗小儿肺炎支原体肺炎疗效好,治疗时间短,安全可靠,值得临床推广。

Objective To observe the clinical efficacy on mycoplasma pneumonia treated with Azithromycin and Tanreqing Injection in children. Methods Ninety cases of mycoplasma pneumonia were randomized into a treatment group（ 45 cases） and a control group（ 45 cases）. In the control group,Azithromycin sequential therapy was applied simply. In the treatment group,on the basis of Azithromycin sequential therapy,Tanreqing Injection was combined. The clinical efficacy was observed in the two groups in terms of antifebrile time,time of cough relief and rales disappearance as well as the absorption improvements. Results The total effective rate was 97. 8% in the treatment group and was 80. 0% in the control group,indicating the significant difference（ P〈0. 05）. The antifebrile time,time of cough relief and rales disappearance as well as the absorption improvements were shorter apparently in the treatment than those in the control group（ P〈0. 05）. Conclusion Azithromycin and Tanreqing Injection in combination achieve the effective results in the treatment of children mycoplasma pneumonia,characterized as short duration of treatment and reliable safety. Hence,this therapy deserves to be promoted clinically.